Skip to content

Clinical trials

Hepatitis C trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Country / region: Austria Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20093
20104
20117
20128
20132
20142
20151
20171
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Unknown status2
Enrolling by invitation1
No longer available1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences6
Bristol-Myers Squibb5
Janssen R&D Ireland4
AbbVie3
Boehringer Ingelheim3
Janssen-Cilag International NV2
Medical University of Vienna2
Tibotec Pharmaceuticals, Ireland2
Vertex Pharmaceuticals Incorporated2
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C37
Hepatitis C, Chronic11
Coinfection2
Fibrosis2
Hepatitis B2
Infections2
Acidosis, Lactic1
Acquired Immunodeficiency Syndrome1
Cardiovascular Diseases1
Diabetes Mellitus1

Trials

Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.